Stocks and Investing Stocks and Investing
Mon, April 1, 2024

Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, Apr 1st, 2024


Published on 2024-10-28 10:00:41 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy and Held Target at $15 on, Apr 1st, 2024.

Andrew, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com